Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker

Figure 4

(a–l) Survival analysis of B4GALNT1 expression using Kaplan-Meier OS curves in ACC, BLCA, CHOL, HNSC, KICH, KIRP, LGG, LIHC, LUAD, MESO, UCEC, and UVM. (m–s) Survival analysis of B4GALNT1 expression using Kaplan-Meier PFI curves in ACC, BLCA, HNSC, KICH, LGG, MESO, and UVM.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)

(s)